Personal genetics company 23andMe will only sell ancestry reports and raw data as controversy with regulators continues.
Physicists have developed a technique that can tell which parts of the brain rely on analog signals and which rely on digital signals.
The U.S. government is concerned that some of 23andMe’s health assessments could mislead customers.
Researchers uncover new ties between genetics and skin cancer by mining patients’ medical records.
High-throughput sequencing takes another step into the clinic with first regulatory approvals.
Three large clinical trials show little benefit to analyzing the genes of patients to find the right dose of blood thinners.
For the first time, researchers report that monkeys can use brain implants to control a left and a right arm.
Dimension Therapeutics wants to develop a lifetime fix for hemophilia using gene therapy.
The way DNA strands contract when they come into contact with viruses could lead to cheap and simple pathogen detectors, say physicists.
Spark Therapeutics hopes to commercialize multiple gene-based treatments developed at the Children's Hospital of Philadelphia.